AQP9 and metabolic dysfunction-associated steatotic liver disease: Interestingly, a decrease in hepatic AQP9 and glycerol permeability has been observed in murine and human NAFLD, suggesting a defensive mechanism to prevent further development of hyperglycemia and hepatosteatosis19, 22, 23.